(Q34046829)

30 July 2017

1 reference

title

New strategies for bone marrow transplantation (English)

1 reference

30 July 2017

1 reference

Slavin S

1

1 reference

30 July 2017

publication date

1 October 2000

1 reference

Current Opinion in Immunology

30 July 2017

published in

1 reference

30 July 2017

volume

12

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

542-551

1 reference

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Transplantation of allogeneic bone marrow without graft-versus-host disease using total lymphoid irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Use of recombinant human interleukin-2 in conjunction with bone marrow transplantation as a model for control of minimal residual disease in malignant hematological disorders: I. Treatment of murine leukemia in conjunction with allogeneic bone marro

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Donor lymphocyte infusions to displace residual host hematopoietic cells after allogeneic bone marrow transplantation for beta-thalassemia major

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Long-term survival of skin allografts in mice treated with fractionated total lymphoid irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Total lymphoid irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Tolerance to donor-type skin in the recipient of a bone marrow allograft. Treatment of skin ulcers in chronic graft-versus-host disease with skin grafts from the bone marrow donor

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Mixed allogeneic chimerism as an approach to transplantation tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Permanent and specific transplantation tolerance induced by a nonmyeloablative treatment to a wide variety of allogeneic tissues: I. Induction of tolerance by a short course of total lymphoid irradiation and selective elimination of the donor-specif

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Transplantation of allogeneic or xenogeneic bone marrow within the donor stromal microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Nonmyeloablative conditioning to induce bilateral tolerance after allogeneic bone marrow transplantation in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Stem cell escalation enables HLA-disparate haematopoietic transplants in leukaemia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Prevention and treatment of graft-versus-host disease by down-regulation of anti-host reactivity with veto cells of host origin.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Transplantation of anergic histoincompatible bone marrow allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Allogeneic hematopoietic transplantation as adoptive immunotherapy. Induction of graft-versus-malignancy as primary therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Mixed hematopoietic chimerism after marrow allografts. Transplantation in the ambulatory care setting

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Mini-allografts: ongoing trials in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Functional clonal deletion versus active suppression in transplantation tolerance induced by total-lymphoid irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Graft-versus-tumour and graft-versus-leukaemia effect in patient with concurrent breast cancer and acute myelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immunized donors

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900136-9

7 January 2021

10.1016/S0952-7915(00)00136-9

Identifiers

DOI

1 reference

30 July 2017

1 reference